Clinical Response of
Normal Tissues
Presenter : Dr. Gowtham Manimaran
Moderator : Dr. Charu Garg
Contents
Concepts – Molecular and cellular aspects
Introduction
Inherent tissue Radiation sensitivity
- Casarett’s Classification
- Michalowski’s population
Kinetics of Normal tissue Radiation injury
- Acute , Subacute, Late responses
Tissue Organisation
- Functional subunits(FSUs), Volume effects
Regeneration
Retreatment - ‘Remembered’ dose
QUANTEC , LENT , SOMA
Cell death
• Major and desired outcome of RT is cell death but occurs in several
different ways.
• Final cellular outcome of RT will depend in part upon how cells and tissues
“perceive damage” through internal and external sensors (hypoxia ,
cytokines, cell-cell , cell -matrix interactions)
Mitotic death
Apoptosis
Necrosis
Autophagy
Senesence
Growth Factors
• IL -1  acts like radioprotectant of hematopoietic cells
• TNF cytotoxic agent , protects hematopoietic cells and sensitises tumour
cells to radiation (regulated at transcription level )
• Basic fibroblast growth factor  induces endothelial growth , inhibits
radiation induced apoptosis and confers protection against microvascular
damage. (produced more in larger blood vessels in response to stress )
• PDGFincreases damage to vascular tissue
• TGF ß  fibrosis , related late changes are attributed to it , they
downregulate IL-1 , TNF and may cause increase damage to hematopoietic
stem cell. (high systemic levels have shown to critically impact outcome)
Bystander effects
• Radiation-induced bystander
effects are defined as biological
effects expressed after irradiation
by cells whose nuclei have not
been directly irradiated.
• These effects include DNA
damage, chromosomal instability,
mutation, and apoptosis.
Abscopal effects
• Local anticancer radiotherapy may
have not only delayed effects but also
distant ones
• Treatment directed at a tumour at
one site can in fact profoundly affect
tumours at other locations in the
body through an effect which R.J.
Mole described more than 60 years
ago as the abscopal effect
• Due to activation of antitumor
immune response involving adaptive
immunity.
Introduction
• Effects of radiation on normal cells is either by their killing action (by
direct DNA damage ) or other mechanisms like cytokine mediated ,
adaptive immunity related ,cell signalling pathways .
• Normal tissue - complete integrated structure , balance between cell
death and birth
• Response to damage governed by
1. Inherent cellular radiosensitivity
2. Kinetics of the tissue
3. The way cells are organized in the tissue
1. Inherent tissue radiosensitivity
• Radiosensitivity of various tissues have been studied in detail based
on histopathological observations.
• Radiosensitivity vs radioresponse
• G2-M phase most sensitive phase to radiation (especially M phase)
• This gave rise to several classification systems,
Casarett’s classification
Michalowski’s classification
Casarett's Classification of Mammalian Cell Radiosensitivity
Exception :
• Small lymphocyte :
They defy all laws and systems of classification
They are believed to never divide at all but they disappear from
blood even after very small doses of radiation
Michalowski Classification
Tissues follow either a hierarchical (H) or flexible (F) model
Within tissues 3 distinct categories of cells
 Stem cells continuously divide and reproduce to give rise to both new stem cells
and cells that eventually give rise to mature functional cells.
 Functional cells, which are fully differentiated; they are usually incapable of further
division and die after a finite life span, though the life span varies enormously
among different cell types. Example- circulatory granulocytes
 Between these two extremes are maturing partially differentiated cells ; these are
descendants of the stem cells, still multiplying as they complete the process of
differentiation. In the bone marrow, for example, the erythroblasts and
granuloblasts represent intermediate compartments
H-type & F-type populations
• Hierarchical (H-type) populations- The cell types that progress from the stem cell
through the mature cell with nonreversible steps along the way Eg: bone marrow,
intestinal epithelium, epidermis.
• Flexible tissue(F-type) populations- The cell lines in which the adult cells can under
certain circumstance be induced to undergo division and reproduce another adult
cell. Eg: include liver parenchymal cells, thyroid cells and pneumocytes.
• Many tissues are hybrids of these two extreme models with most cells able to make a
few divisions and minority behaving as stem cells
2. Kinetics of normal tissue
• Rate of tissue turnover i.e (rate of loss vs regeneration) is as
important as size of dose per fraction for defining response to
radiation.
• Tissues dose responses are characterised by their different a/ß ratios
(Late effects more sensitive to changes in fractionation than early
effects)
Early effects
Consequential late effects
Subacute
Late effects
Acute Responses/effects
• Early (acute) effects result from death of large number of cells and
occur within a standard of 6-8 weeks / even days after irradiation in
tissues with rapid rate of turnover
• Repaired rapidly because of rapid proliferation of stem cells
• May be completely reversible
Examples:
• Epidermal layer of skin
• Gastrointestinal epithelium
• Hematopoietic system
• Severity of acute injury increases with dose
Consequential late effects
• A severe acute radiation may deplete the complete stem cell
population leading to nonspecific late (consequential) changes which
may remain as a chronic injury .
Eg:
1. stenosis as a consequence to mucosal ulceration of the bowel
(unable to regenerate heals by fibrosis)
2. Bone marrow suppression following intense fractionation
3. Fibrosis /necrosis of skin consequential to early reaction of
desquamation
Subacute effects
• Occurring during 3 months to 6 months of completion of Radiation
treatment
• Symptoms often reversible but might progress to severe damage
and even death
• Eg: Lhermitte syndrome ,Radiation pneumonitis
Late effects
• Occurring even after 6 months of completion of Radiation treatment.
• Eg: Lung, Kidney, Heart, Central nervous system
• The damage might improve but never completely repaired and are mostly
fatal
• Late effects are more sensitive to increase in dose per fraction
• An issue of growing clinical importance ! – can it be reversed/treated ?
Eg: Captopril , an ACE inhibitor has shown to slow radiation nephritis and
lung fibrosis in rats
• Reflection of dysregulated immune homeostasis – reestablising it is the
only way for complete treatment
3. Tissue organisation
• FSU (Functional subunits) - Defined as a tissue unit able to recover from
one surviving clonogen.
• FSUs depends on survival of one or more clonogenic cells within them and
tissue survival in turn depends on the number and radiosensitivity of these
clonogens.
1. Structurally defined FSUs:
Ex : Kidney Nephrons are the FSUs , but dose tolerance for kidney depends more
upon the number of tubule/stem cells per nephron than the number of nephrons
Other examples with clear demarcation are : salivary glands, pancreas , sweat
glands , mammary epithelium , spinal cord , nerve tracts
2. Undefined FSUs:
Ex: Dermis , mucosa , gut epitheliumclonogenic cells can migrate between FSUs
• Exception : Jejunum
Serial organs :
• complications occur even when small segments
of the organ are damaged.
Ex: Spinal cord , brain stem , optic nerve ,chiasma
Parallel organs :
• sub-volumes of the organ function relatively
independently
• Complications develop when critical volumes are
injured.Hene the volume of tissue exposed to
radiation is more important
Ex: Lungs , liver , kidney
Volume Effect in
Radiotherapy
• Traditionally , we reduce total
dose when treating large
volumes of normal tissue
• In reality , the concept of
decreasing dose with increasing
volume has little radiobiologic
basis , except in specific
circumstances
• Ex :Tissues with FSUs arranged
in series like spinal cordloss of
one FSUs may result in a state of
injury irrespective of the other
FSUs
Other Volume effects : (not related to cell death)
• A small area of injury is tolerated better than a large area of the same
severity. Pain, fluid leakage, and inflammation worse, healing slower
• Dose heterogenecity across the field.
• If organ “reserve” is obliterated as volume is increased (e.g., lung, salivary
gland). This is not a true volume effect because sequelae are determined
by the volume and functional status of the tissue excluded from the
treatment volume, not the volume irradiated.
Regeneration
• In acute responding cells , repopulation starts early because cell loss
in rapid.
• The current standard protracted treatment times confer a benefit by
allowing regeneration of acute responding tissues.
• When attempts are made to accelerate treatment , acute responses
become more severe and dose limiting.
• Mitigators of radiation damage capable of accelerating recovery are
being used
Ex: G-CSF, GM-CSF ,KGF (keratinocyte growth factor)
Tolerance to retreatment
• According to conventional wisdom , heavily irradiated tissue cannot
be retreated because of irreversible vascular damage
• But although prior RT may decrease tissue tolerance , retreatment is
often possible and may be better tolerated .
• Factors determing :
Tissue at risk
Amount of initial cell depletion
Time elapsed since treatment extent of regeneration
QUANTEC
Quantitative Analysis of Normal Tissue Effects in the Clinic
Published in the International Journal of Radiation Oncology, Biology,
and Physicsin 2010 (IJROBP)
64
Implications of QUANTEC
• Different mechanisms for radiation-induced injury in different organs
• Serially arranged organ have steep dose–response curves at doses beyond an
apparent critical threshold
• Several neural structures exhibit a similar threshold dose for injury,so there is
common mechanism of injury
• Organs that are classically considered structured in parallel (e.g., lung, liver,
parotid, and kidney, analogous to electrical circuits) experience injury at far lower
doses and have more gradual dose–response curves compared to series organs
• QUANTEC better quantify the relationship between dose –volume parameters
and clinical outcomes.
66
LENT AND SOMA
• European Organization for Research and Treatment of Cancer (EORTC) and
the Radiation Therapy Oncology Group (RTOG), formed working groups to
update their system for assessing late injury to normal tissues
• This led to the Late Effects of Normal Tissue (LENT) conference in
1992This conference led to the introduction of the SOMA
• SOMA is an acronym for subjective, objective, management criteria with
analytic laboratory and imaging procedures
Central Nervous System - SOMA62
LENTand SOMA Scoring Systemand Grading Categories
Grade I Grade II Grade III Grade IV
Subjective
(pain)
Occasional and
minimal
Intermittent
and tolerable
Persistent and
intense
Refractory and
excruciating
Objective
(neurological
defect)
Barely
Detectable
Easily
Detectable
Focal Motor
sign, vision and
disturbances
Hemiplegia,
Hemisensory
defect
Management
(pain)
Occasional
nonnarcotic
Regular
nonnarcotic
Regular
narcotic
Surgical
intervenrion
Analytic (CT,
MRI, Lab Tests)
Thank you
67

Gowtham's 3rd radiobiology

  • 1.
    Clinical Response of NormalTissues Presenter : Dr. Gowtham Manimaran Moderator : Dr. Charu Garg
  • 2.
    Contents Concepts – Molecularand cellular aspects Introduction Inherent tissue Radiation sensitivity - Casarett’s Classification - Michalowski’s population Kinetics of Normal tissue Radiation injury - Acute , Subacute, Late responses Tissue Organisation - Functional subunits(FSUs), Volume effects Regeneration Retreatment - ‘Remembered’ dose QUANTEC , LENT , SOMA
  • 3.
    Cell death • Majorand desired outcome of RT is cell death but occurs in several different ways. • Final cellular outcome of RT will depend in part upon how cells and tissues “perceive damage” through internal and external sensors (hypoxia , cytokines, cell-cell , cell -matrix interactions) Mitotic death Apoptosis Necrosis Autophagy Senesence
  • 4.
    Growth Factors • IL-1  acts like radioprotectant of hematopoietic cells • TNF cytotoxic agent , protects hematopoietic cells and sensitises tumour cells to radiation (regulated at transcription level ) • Basic fibroblast growth factor  induces endothelial growth , inhibits radiation induced apoptosis and confers protection against microvascular damage. (produced more in larger blood vessels in response to stress ) • PDGFincreases damage to vascular tissue • TGF ß  fibrosis , related late changes are attributed to it , they downregulate IL-1 , TNF and may cause increase damage to hematopoietic stem cell. (high systemic levels have shown to critically impact outcome)
  • 5.
    Bystander effects • Radiation-inducedbystander effects are defined as biological effects expressed after irradiation by cells whose nuclei have not been directly irradiated. • These effects include DNA damage, chromosomal instability, mutation, and apoptosis.
  • 6.
    Abscopal effects • Localanticancer radiotherapy may have not only delayed effects but also distant ones • Treatment directed at a tumour at one site can in fact profoundly affect tumours at other locations in the body through an effect which R.J. Mole described more than 60 years ago as the abscopal effect • Due to activation of antitumor immune response involving adaptive immunity.
  • 7.
    Introduction • Effects ofradiation on normal cells is either by their killing action (by direct DNA damage ) or other mechanisms like cytokine mediated , adaptive immunity related ,cell signalling pathways . • Normal tissue - complete integrated structure , balance between cell death and birth • Response to damage governed by 1. Inherent cellular radiosensitivity 2. Kinetics of the tissue 3. The way cells are organized in the tissue
  • 8.
    1. Inherent tissueradiosensitivity • Radiosensitivity of various tissues have been studied in detail based on histopathological observations. • Radiosensitivity vs radioresponse • G2-M phase most sensitive phase to radiation (especially M phase) • This gave rise to several classification systems, Casarett’s classification Michalowski’s classification
  • 9.
    Casarett's Classification ofMammalian Cell Radiosensitivity
  • 10.
    Exception : • Smalllymphocyte : They defy all laws and systems of classification They are believed to never divide at all but they disappear from blood even after very small doses of radiation
  • 11.
    Michalowski Classification Tissues followeither a hierarchical (H) or flexible (F) model Within tissues 3 distinct categories of cells  Stem cells continuously divide and reproduce to give rise to both new stem cells and cells that eventually give rise to mature functional cells.  Functional cells, which are fully differentiated; they are usually incapable of further division and die after a finite life span, though the life span varies enormously among different cell types. Example- circulatory granulocytes  Between these two extremes are maturing partially differentiated cells ; these are descendants of the stem cells, still multiplying as they complete the process of differentiation. In the bone marrow, for example, the erythroblasts and granuloblasts represent intermediate compartments
  • 12.
    H-type & F-typepopulations • Hierarchical (H-type) populations- The cell types that progress from the stem cell through the mature cell with nonreversible steps along the way Eg: bone marrow, intestinal epithelium, epidermis. • Flexible tissue(F-type) populations- The cell lines in which the adult cells can under certain circumstance be induced to undergo division and reproduce another adult cell. Eg: include liver parenchymal cells, thyroid cells and pneumocytes. • Many tissues are hybrids of these two extreme models with most cells able to make a few divisions and minority behaving as stem cells
  • 13.
    2. Kinetics ofnormal tissue • Rate of tissue turnover i.e (rate of loss vs regeneration) is as important as size of dose per fraction for defining response to radiation. • Tissues dose responses are characterised by their different a/ß ratios (Late effects more sensitive to changes in fractionation than early effects) Early effects Consequential late effects Subacute Late effects
  • 14.
    Acute Responses/effects • Early(acute) effects result from death of large number of cells and occur within a standard of 6-8 weeks / even days after irradiation in tissues with rapid rate of turnover • Repaired rapidly because of rapid proliferation of stem cells • May be completely reversible Examples: • Epidermal layer of skin • Gastrointestinal epithelium • Hematopoietic system • Severity of acute injury increases with dose
  • 15.
    Consequential late effects •A severe acute radiation may deplete the complete stem cell population leading to nonspecific late (consequential) changes which may remain as a chronic injury . Eg: 1. stenosis as a consequence to mucosal ulceration of the bowel (unable to regenerate heals by fibrosis) 2. Bone marrow suppression following intense fractionation 3. Fibrosis /necrosis of skin consequential to early reaction of desquamation
  • 16.
    Subacute effects • Occurringduring 3 months to 6 months of completion of Radiation treatment • Symptoms often reversible but might progress to severe damage and even death • Eg: Lhermitte syndrome ,Radiation pneumonitis
  • 17.
    Late effects • Occurringeven after 6 months of completion of Radiation treatment. • Eg: Lung, Kidney, Heart, Central nervous system • The damage might improve but never completely repaired and are mostly fatal • Late effects are more sensitive to increase in dose per fraction • An issue of growing clinical importance ! – can it be reversed/treated ? Eg: Captopril , an ACE inhibitor has shown to slow radiation nephritis and lung fibrosis in rats • Reflection of dysregulated immune homeostasis – reestablising it is the only way for complete treatment
  • 18.
    3. Tissue organisation •FSU (Functional subunits) - Defined as a tissue unit able to recover from one surviving clonogen. • FSUs depends on survival of one or more clonogenic cells within them and tissue survival in turn depends on the number and radiosensitivity of these clonogens. 1. Structurally defined FSUs: Ex : Kidney Nephrons are the FSUs , but dose tolerance for kidney depends more upon the number of tubule/stem cells per nephron than the number of nephrons Other examples with clear demarcation are : salivary glands, pancreas , sweat glands , mammary epithelium , spinal cord , nerve tracts 2. Undefined FSUs: Ex: Dermis , mucosa , gut epitheliumclonogenic cells can migrate between FSUs • Exception : Jejunum
  • 19.
    Serial organs : •complications occur even when small segments of the organ are damaged. Ex: Spinal cord , brain stem , optic nerve ,chiasma Parallel organs : • sub-volumes of the organ function relatively independently • Complications develop when critical volumes are injured.Hene the volume of tissue exposed to radiation is more important Ex: Lungs , liver , kidney
  • 20.
    Volume Effect in Radiotherapy •Traditionally , we reduce total dose when treating large volumes of normal tissue • In reality , the concept of decreasing dose with increasing volume has little radiobiologic basis , except in specific circumstances • Ex :Tissues with FSUs arranged in series like spinal cordloss of one FSUs may result in a state of injury irrespective of the other FSUs
  • 21.
    Other Volume effects: (not related to cell death) • A small area of injury is tolerated better than a large area of the same severity. Pain, fluid leakage, and inflammation worse, healing slower • Dose heterogenecity across the field. • If organ “reserve” is obliterated as volume is increased (e.g., lung, salivary gland). This is not a true volume effect because sequelae are determined by the volume and functional status of the tissue excluded from the treatment volume, not the volume irradiated.
  • 22.
    Regeneration • In acuteresponding cells , repopulation starts early because cell loss in rapid. • The current standard protracted treatment times confer a benefit by allowing regeneration of acute responding tissues. • When attempts are made to accelerate treatment , acute responses become more severe and dose limiting. • Mitigators of radiation damage capable of accelerating recovery are being used Ex: G-CSF, GM-CSF ,KGF (keratinocyte growth factor)
  • 23.
    Tolerance to retreatment •According to conventional wisdom , heavily irradiated tissue cannot be retreated because of irreversible vascular damage • But although prior RT may decrease tissue tolerance , retreatment is often possible and may be better tolerated . • Factors determing : Tissue at risk Amount of initial cell depletion Time elapsed since treatment extent of regeneration
  • 24.
    QUANTEC Quantitative Analysis ofNormal Tissue Effects in the Clinic Published in the International Journal of Radiation Oncology, Biology, and Physicsin 2010 (IJROBP) 64
  • 26.
    Implications of QUANTEC •Different mechanisms for radiation-induced injury in different organs • Serially arranged organ have steep dose–response curves at doses beyond an apparent critical threshold • Several neural structures exhibit a similar threshold dose for injury,so there is common mechanism of injury • Organs that are classically considered structured in parallel (e.g., lung, liver, parotid, and kidney, analogous to electrical circuits) experience injury at far lower doses and have more gradual dose–response curves compared to series organs • QUANTEC better quantify the relationship between dose –volume parameters and clinical outcomes. 66
  • 27.
    LENT AND SOMA •European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG), formed working groups to update their system for assessing late injury to normal tissues • This led to the Late Effects of Normal Tissue (LENT) conference in 1992This conference led to the introduction of the SOMA • SOMA is an acronym for subjective, objective, management criteria with analytic laboratory and imaging procedures
  • 28.
  • 29.
    LENTand SOMA ScoringSystemand Grading Categories Grade I Grade II Grade III Grade IV Subjective (pain) Occasional and minimal Intermittent and tolerable Persistent and intense Refractory and excruciating Objective (neurological defect) Barely Detectable Easily Detectable Focal Motor sign, vision and disturbances Hemiplegia, Hemisensory defect Management (pain) Occasional nonnarcotic Regular nonnarcotic Regular narcotic Surgical intervenrion Analytic (CT, MRI, Lab Tests)
  • 30.

Editor's Notes

  • #4 Mitotic death after irradiation was observed first in 1956 by Puck and Marcus.Most commonest type of cell death. M phase, chromothripsis can catastrophic shattering event Apoptosis – interphase death ex :lymphocytes , salivary gland , thyroid , intestinal crypts (not always intrinsic (bax , bak) also with extrinsic (TNF , death domain) Necrosis – cell membrane integrity lost , cells swell , lysosomal enzymes released  necroptosis (TNF alpha) , pyroptosis (IL-1 BETA, IL -18) Autophagy – seen in nutrition deprivation , internalise their own cellular organelles Senescence – production of antiproliferative cytokines like IL 6 , TDG BETA-->collagen formation leading to long standing effects
  • #6 Mothersill et al.6,7 These findings suggest that the direct effect of fractionated radiotherapy would be to spare the tissues receiving the direct dose, whereas the unirradiated cells that receive signals from nearby irradiated tissue would respond to each fraction as a unique dose. As a result, over a very large dose range, fractionating the dose does not result in any sparing effect for adjacent cells that receive bystander signals rather than direct doses. Again, this effect would be likely to negatively affect the therapeutic ratio. For this reason, it is essential to evaluate the effect of fractionating doses in an in vivo model.
  • #10  Vegetative Intermitotic Cells.(VIM)-Undifferentiated rapidly dividing cells which generally have a quite short life Differentiating Intermitotic Cells (DIM)-Actively mitotic cells with some level of differentiation. Spermatogonia are a prime example as well as midlevel cells in differentiating cell lines.Have substantial reproductive capability but will eventually stop dividing or mature into a differentiate cell line  Reverting Postmitotic Cells (RPM)-Does not normally undergo division but can do so if called upon by the body ex :liver , kidney Fixed Postmitotic Cells (FPM)  Most resistant to radiation  Highly differentiated and lost ability to divide  May have long (neurone) and short life span (granulocyte)
  • #11 Clinically lymphopenia  caution of adding prophylactic antibiotics (trimethoprim–sulfamethoxazole (TMP/SMX) –gastric tolerance and broad spectrum) They die an interphase death
  • #17 Lheremitte syndrome – after spinal cord irradiation , due to diffuse demyelination Radaition pneumonitis -Radiation pneumonitis: Atypia of type II pneumocytes Alveolar wall edema Infiltration of inflammatory cells in the interstitium Aggregation of alveolar macrophage Hyaline membranes lining alveolar ducts and alveoli Pathophysiology Two separate and distinct mechanisms are involved in the pathogenesis of acute radiation pneumonitis.  The first, classical radiation pneumonitis, involves direct toxic injury to endothelial and epithelial cells from the radiation.  The accumulation of leukocytes distorts the normal alveolar structures resulting initially in  an acute aveolitis at the site of radiation.  The alveolar macrophage is thought to play a  central role in the subsequent development of  fibrosis. The second mechanism, sporadic radiation  pneumonitis, results in an "out-of-field"  response. This is thought to be an  immunologically mediated process resulting in  bilateral lymphocytic aveolitis.
  • #18 Caution for late and subacute !!! – because both appear after completion of treatment mostly hence dose adjustment is obviously not an option Now a days due to advances in medicine average life span has increased which also a reason for apparent increase in late effects!!
  • #19 Definition of clonogenic cell – a survivor that has retained its reproductive ability and is able to proliferate indefinitely to produce a large colony of clones are called clonogenic.  Crypts of jejunum (structurally well defined but surviving crypts can/do migrate from one crypt to another to repopulate depleted neighbors
  • #20 DVHs do not represent all organ-specific spatial radiation dose information, hence assume all regions are of equal functional importance, and they often do not consider fractionation schemas. Spinal cord conventional : 45-50 Gy Optic Chiasma and nerve : Dmax <55 Gy B/L whole kidney - Dmean < 15-18 Gy - V12 < 55% , V20 <32% , V23 <30% , V28 < 20%
  • #21 Curve A relates to a normal tissue in which the functional subunits are not arranged serially regardless of whether one or all subunits are exposed (i.e., regardless of field size). It also applies to a normal tissue in which functional subunits are arranged serially if only one subunit is exposed (i.e., if the field is small). Note that the curve is relatively shallow (i.e., the probability of a complication rises relatively slowly with dose). Curves B and C refer to a tissue with serially arranged functional subunits; the complication curve gets steeper and moves to lower doses as the treatment field size increases.
  • #22  Increased toxicity with bleomycin, cyclophosphamide
  • #23 KGF – palifermin60 ug /kg/day GM-CSF  SARGRAMOSTIM , REGRAMOSTIM G CSFpegfilgastrim , filgastrim
  • #24 (high prior doses , a short interval , slow regeneration will reduce retreatment toelrance)